Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating Expenses:
Research and development expenses	$ 207,128	$ 696,073	$ 1,002,640	$ 1,418,467
General and administrative expenses	1,150,808	1,858,550	4,101,466	6,843,513
Total Operating Expenses	1,357,936	2,554,623	5,104,106	8,261,980
Loss From Operations	(1,357,936)	(2,554,623)	(5,104,106)	(8,261,980)
Other Income (Expense)
Interest income	10,236	3,472	58,554	15,517
Other income (expenses)			(51,901)
Total other income (expense)	10,236	3,472	6,653	15,517
Loss Before Provision For Income Taxes	(1,347,700)	(2,551,151)	(5,097,453)	(8,246,463)
Provision for income taxes
Loss from Continuing Operations	(1,347,700)	(2,551,151)	(5,097,453)	(8,246,463)
Income (loss) from discontinued operations, net of taxes, including gain on disposal of $2,624,798	(37,276)	(558,199)	1,894,445	(1,618,258)
Net Loss	$ (1,384,976)	$ (3,109,350)	$ (3,203,008)	$ (9,864,721)
Loss per share from continuing operations, basic (in Dollars per share)	$ (1.14)	$ (2.48)	$ (4.54)	$ (8.31)
Income (Loss) per share from discontinued operations, basic (in Dollars per share)	(0.03)	(0.54)	1.69	(1.63)
Net loss per share, basic (in Dollars per share)	$ (1.18)	$ (3.02)	$ (2.86)	$ (9.94)
Weighted average shares, basic (in Shares)	1,178,537	1,028,982	1,121,328	992,156